School of Medicine

Jeffrey I. Gordon, MD, of Washington University School of Medicine in St. Louis, and Yoram Rudy, of the School of Engineering & Applied Science, and have been selected as National Academy of Inventors fellows. They will be inducted in April at a ceremony during the academy’s annual meeting in Houston.

Researchers at the School of Medicine — working with mice with sleep problems similar to those experienced by people with the genetic disease neurofibromatosis type 1 (NF1) — believe the animals will help shed light on insomnia linked to NF1 or other factors.

A new study at the School of Medicine finds disparities between African-Americans and Caucasians in a key biomarker for Alzheimer’s disease — suggesting that tools to diagnose the disease in Caucasian populations may not work as well in African-Americans.

Scientists at the School of Medicine have identified a previously unknown route for cellular fuel delivery, a finding that could shed light on the process of aging and the chronic diseases that often accompany it.

A Washington University in St. Louis interdisciplinary initiative has sparked a wave of faculty research and the publication of a new book examining the incidence of cancer among low-income women of color in St. Louis and the Metro East communities of Illinois, including East St. Louis.

Rick W. Wright, MD, the Jerome J. Gilden Distinguished Professor of Orthopaedic Surgery at Washington University School of Medicine in St. Louis, has been named president-elect of the American Board of Orthopaedic Surgery. Wright will serve a one-year term as president-elect and become president of the organization in October.

A team of neuroscientists and engineers, including some at the School of Medicine, has developed a tiny, implantable device that has potential to help people with bladder problems bypass the need for medication or electronic stimulators.

A study from the School of Medicine suggests that people over 65 who are newly diagnosed with heart failure can continue to drink moderate amounts of alcohol without worsening their condition.

A new study from the School of Medicine shows that the common acne medication isotretinoin alters the microbiome of the skin. The study raises the possibility of developing microbiome-based acne treatments.

Tuberculosis expert Jennifer Philips, MD, PhD, associate professor of medicine, has been named co-director of the Division of Infectious Diseases in the Department of Medicine at Washington University School of Medicine in St. Louis.